News
Vertex’s Kalydeco obtains FDA approval to treat CF in children
Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its Kalydeco (ivacaftor) to treat cystic fibrosis (CF) in children...
News
PARP inhibitors effective against cancer cells with fault CBLC gene, says ICR
Researchers at London's Institute of Cancer Research (ICR) have found that cancer cells with a fault in the protein-coding CBLC gene could be sensitive...
Press Releases
Global Vision Announces Partnership with Israeli Reseller Dor Pharmaceutical Services
Global Vision is proud to announce that its proofreading technologies are available to support growing demand from pharmaceutical companies in Israel. ...
News
Actavis acquires Botox-maker Allergan for $70.5bn
Actavis has completed the acquisition of US-based Botox-maker Allergan, in a deal valued around $70.5bn. With combined annual pro forma revenues...
Press Releases
Endress+Hauser Reveals One in 16 Associates Works in Research
One in 16 people working for the Endress+Hauser Group is employed in R&D. In 2014, Endress+Hauser filed more patents than ever...
Press Releases
Eppendorf Announces New BioFlo 320 Bench Scale Bioprocess Control Station
Eppendorf has announced the release of BioFlo 320 Bench Scale Bioprocess Control Station. The station features autoclavable and single-use vessel flexibility,...
Press Releases
Eppendorf Announces New BioBLU 50c Single-use Vessel Adaptor Kits
Eppendorf has announced the release of a brand new line of BioBLU 50c single-use Vessel Adaptor Kits. The convenient adaptor kits...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read